Patents Assigned to Advantek Serum Laboratories Ltd.
  • Production of high purity chondroitinase ABC
    Patent number: 10214738
    Abstract: The present invention provides a method for purifying Chondroitinase ABC (ChABC). The present method includes using a heparin-immobilized affinity chromatography column, and through chromatography method obtaining a purified ChABC from a matrix containing the ChABC. The present method is capable of obtaining ChABC in high purity with the advantages of simplicity in preparation and high yield.
    Type: Grant
    Filed: July 30, 2018
    Date of Patent: February 26, 2019
    Assignee: Advantek Serum Laboratories Ltd.
    Inventors: Bing Lou Wong, Wai Hong Chung
  • Production of high purity chondroitinase ABC
    Patent number: 10036004
    Abstract: The present invention provides a method for purifying Chondroitinase ABC (ChABC). The present method includes using a heparin-immobilized affinity chromatography column, and through chromatography method obtaining a purified ChABC from a matrix containing said ChABC. The present method is capable of obtaining ChABC in high purity with the advantages of simplicity in preparation and high yield.
    Type: Grant
    Filed: October 20, 2017
    Date of Patent: July 31, 2018
    Assignee: Advantek Serum Laboratories Ltd
    Inventors: Bing Lou Wong, Wai Hong Chung
  • Production of high purity chondroitinase ABC
    Patent number: 9796970
    Abstract: The present invention provides a method for purifying Chondroitinase ABC (ChABC). The present method includes using a heparin-immobilized affinity chromatography column, and through chromatography method obtaining a purified ChABC from a matrix containing the ChABC. The present method is capable of obtaining ChABC in high purity with the advantages of simplicity in preparation and high yield.
    Type: Grant
    Filed: April 24, 2017
    Date of Patent: October 24, 2017
    Assignee: Advantek Serum Laboratories Ltd.
    Inventors: Bing Lou Wong, Wai Hong Chung